E-LIB Suche - Ergebnisse für: Modest, D.P.

1

Evaluation of the inflammation-based modified Glasgow Progn..:

Boukovala, M. ; Modest, D.P. ; Ricard, I....
ESMO Open. 9 (2024) 5 - p. 103374 , 2024

Link: https://doi.org/10.1016/..

2

32P Patient-reported tolerability of sotorasib (soto) and p..:

Taieb, J. ; Fakih, M. ; Salvatore, L....
Annals of Oncology. 35 (2024) - p. S16-S17 , 2024

Link: https://doi.org/10.1016/..

3

59P Matching-adjusted indirect treatment comparisons (MAIC)..:

Salvatore, L. ; Fakih, M. ; Kuboki, Y....
Annals of Oncology. 35 (2024) - p. S28-S29 , 2024

Link: https://doi.org/10.1016/..

4

Dermatology-related quality-of-life outcomes in patients wi..:

Ballhausen, A. ; Karthaus, M. ; Fruehauf, S....
ESMO Open. 9 (2024) 7 - p. 103628 , 2024

Link: https://doi.org/10.1016/..

5

66P Targeted treatment (TT) after immune checkpoint inhibit..:

Ambrosini, M. ; Tougeron, D. ; Modest, D.P....
Annals of Oncology. 35 (2024) - p. S32 , 2024

Link: https://doi.org/10.1016/..

6

Impact of sex on the efficacy and safety of panitumumab plu..:

Heinrich, K. ; Karthaus, M. ; Fruehauf, S....
ESMO Open. 8 (2023) 4 - p. 101568 , 2023

Link: https://doi.org/10.1016/..

7

Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a pr..:

Sommerhäuser, G. ; Kurreck, A. ; Stintzing, S....
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

8

Dynamics in treatment response and disease progression of m..:

Kurreck, A. ; Geissler, M. ; Martens, U. M....
Journal of Cancer Research and Clinical Oncology. 146 (2020) 10 - p. 2681-2691 , 2020

Link: https://doi.org/10.1007/..

9

Therapie kolorektaler und nichtkolorektaler Lebermetastasen..:

Gül-Klein, S. ; Schmuck, R. ; Modest, D. P..
Der Chirurg. 91 (2020) 5 - p. 396-404 , 2020

Link: https://doi.org/10.1007/..

10

Relevance of baseline carcinoembryonic antigen for first-li..:

Holch, J.W. ; Ricard, I. ; Stintzing, S....
European Journal of Cancer. 106 (2019) - p. 115-125 , 2019

Link: https://doi.org/10.1016/..

11

Consensus molecular subgroups (CMS) of colorectal cancer (C..:

Stintzing, S. ; Wirapati, P. ; Lenz, H.-J....
Annals of Oncology. 30 (2019) 11 - p. 1796-1803 , 2019

Link: https://doi.org/10.1093/..

12

Treatment sequencing in metastatic colorectal cancer:

Modest, D.P. ; Pant, S. ; Sartore-Bianchi, A.
European Journal of Cancer. 109 (2019) - p. 70-83 , 2019

Link: https://doi.org/10.1016/..

13

Surgical treatment options following chemotherapy plus cetu..:

Modest, D.P. ; Denecke, T. ; Pratschke, J....
European Journal of Cancer. 88 (2018) - p. 77-86 , 2018

Link: https://doi.org/10.1016/..

14

FOLFOXIRI plus bevacizumab as conversion-therapy for liver ..:

Modest, D.P. ; Neumann, U.P. ; Pratschke, J.
European Journal of Cancer. 73 (2017) - p. 71-73 , 2017

Link: https://doi.org/10.1016/..

15

Evaluation of survival across several treatment lines in me..:

Modest, D.P. ; Ricard, I. ; Stintzing, S....
European Journal of Cancer. 84 (2017) - p. 262-269 , 2017

Link: https://doi.org/10.1016/..